Concepedia

Lucia Vincenzetti

LV

Statistics

Publications

5

Citations

293

H-Index

5

Active since

2019

Affiliations

Vir Biotechnology (Switzerland)(Current)

VIR Biotechnology (United States)

Università della Svizzera italiana

Howard Hughes Medical Institute

University of Utah

Lucia Vincenzetti is an author at Vir Biotechnology (Switzerland) specializing in infectious diseases, immunology, and vaccinology.

Publications per year

2019–2025

5

Publications

5

Neutralization, effector function and immune imprinting of Omicron variants

Amin Addetia, Luca Piccoli, James Brett Case et al. · Nature · 2023 · 181 citations · Full text

, , +14

Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice

Florian A. Lempp, Tassilo Volz, Elisabetta Cameroni et al. · Journal of Hepatology · 2023 · 51 citations · Full text

, , +17

Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants

Amin Addetia, Luca Piccoli, James Brett Case et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 31 citations · Full text

, , +17

The contribution of active and passive mechanisms of 5mC and 5hmC removal in human T lymphocytes is differentiation‐ and activation‐dependent

Lucia Vincenzetti, Cristina Leoni, Michele Chirichella et al. · European Journal of Immunology · 2019 · 20 citations · Full text

, , +15

Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells

Lucia Vincenzetti, Rachel Wong, Roberta Marzi et al. · Journal of Hepatology · 2025 · 10 citations

, , +13

1–5 of 5